Identifying Key Sources for Establishing OMERACT's Notability

edit

@Kvng Thank you so much for your feedback! We’ve taken your suggestion and identified what we believe are the three best sources that establish OMERACT's notability:

  1. Tugwell, Peter et al. (2007), "OMERACT: An international initiative to improve outcome measurement in rheumatology," Trials. This article highlights OMERACT's global impact on rheumatology clinical trials and its collaborations with key health organizations like WHO and EULAR. It also outlines the core sets of measures that have become central to rheumatology research.
  2. "Rheumatology's Divergent Thinkers" (The Rheumatologist, 2024). This piece emphasizes OMERACT’s innovative role in rheumatology, showcasing its influence and the important contributions of its key members in shaping outcome measures in the field.
  3. "OMERACT continues to set standards on research outcomes, enhancing the patient voice" (MDedge, 2022). This article provides a more recent look at how OMERACT continues to evolve, especially in integrating patient perspectives into its work and ensuring its methodologies remain cutting-edge.

I hope this helps, and thanks again for your guidance! Sgrosskleg (talk) 15:52, 10 September 2024 (UTC)Reply

Thanks, these sources appear to be reliable, independent and demonstrate interest in the topic over a significant time period. Thanks for doing the homework. ~Kvng (talk) 20:31, 10 September 2024 (UTC)Reply